Anlito, Sandro M.
HRN: 23-58-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/30/2023
09/06/2023
IVTT
75mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes